From the Latest RGH Bulletin:
Women with a history of breast cancer can have more frequent and severe vasomotor symptoms than the general population of women. This is due in part to the use of tamoxifen and aromatase inhibitors. As with all women, the management of vasomotor symptoms and symptoms of vaginal atrophy in women with a history of breast cancer requires an individualised, patient centred multidisciplinary approach, based upon the woman’s expectations and goals of therapy
The 2009 RGH E-Bulletins are archived by topic here.
If you like this post and what else you see on the blog please subscribe by RSS feed (the orange button) or by email. Visit my subscription page.
{ 9 comments }
